Hanna H Kakish

Jun 11, 2024 | mdpi.com | Hanna H Kakish |Fasih Ahmed |Lee Ocuin |Jennifer L. Miller-Ocuin

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Feb 9, 2024 | onlinelibrary.wiley.com | Hanna H Kakish |Mohammed O. Suraju |Erik Davis |Abhinav Seth

1 INTRODUCTION Hepatocellular carcinoma (HCC) is the most common primary liver tumor globally, and it is the second leading cause of cancer-related mortality.1, 2 The incidence of HCC has been increasing in the United States.3 It is estimated that there were 25 606 new cases of HCC diagnosed in 2013, but in 2030, over 55 000 new cases are expected.4 About 40%–75% of patients with HCC present with multifocal disease, that is, Multifocal Hepatocellular Carcinoma (MHCC) at diagnosis, which is...

Nov 20, 2023 | onlinelibrary.wiley.com | Hanna H Kakish |Claire Drigotas |Fasih Ahmed |Mohamedraed Elshami

Background and Objectives There is no consensus guidelines on the best timing to perform Sentinel lymph node biopsy (SLNB) in high-risk melanoma patients. We aimed to understand the impact of surgical timing on nodal upstaging in patients with cutaneous melanoma. Methods We queried the National Cancer Database from 2004 to 2018 for patients with T2–T4, N0, M0 melanomas, who underwent melanoma excision and nodal surgery.